132 related articles for article (PubMed ID: 17352362)
1. Designing risk-adapted therapy for multiple myeloma: the Mayo perspective.
Lonial S
Mayo Clin Proc; 2007 Mar; 82(3):279-81. PubMed ID: 17352362
[No Abstract] [Full Text] [Related]
2. [Autologous stem cell transplantation in multiple myeloma - pro].
Goldschmidt H
Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555
[No Abstract] [Full Text] [Related]
3. Myeloma (multiple).
Kumar A; Djulbegovic B
Clin Evid; 2006 Jun; (15):1-29. PubMed ID: 16973003
[No Abstract] [Full Text] [Related]
4. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Dispenzieri A; Rajkumar SV; Gertz MA; Fonseca R; Lacy MQ; Bergsagel PL; Kyle RA; Greipp PR; Witzig TE; Reeder CB; Lust JA; Russell SJ; Hayman SR; Roy V; Kumar S; Zeldenrust SR; Dalton RJ; Stewart AK
Mayo Clin Proc; 2007 Mar; 82(3):323-41. PubMed ID: 17352369
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
[TBL] [Abstract][Full Text] [Related]
6. [The importance of autologous transplantation in multiple myeloma].
Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
[TBL] [Abstract][Full Text] [Related]
7. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
8. Thalidomide maintenance in multiple myeloma: certainties and controversies.
Cavo M; Pantani L; Tacchetti P; Pallotti MC; Brioli A; Petrucci A; Zamagni E; Tosi P
J Clin Oncol; 2009 Nov; 27(32):e186-7; author reply e188. PubMed ID: 19770366
[No Abstract] [Full Text] [Related]
9. [High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities].
Rácil Z; Adam Z; Hájek R; Tomíska M; Krejcí M; Krivanová A; Höklová J; Doubek M; Mayer J; Vorlícek J
Vnitr Lek; 2001 Feb; 47(2):92-8. PubMed ID: 15635853
[TBL] [Abstract][Full Text] [Related]
10. Autologous and allogeneic transplants for multiple myeloma.
Barlogie B; Jagannath S; Vesole D; Tricot G
Semin Hematol; 1995 Jan; 32(1):31-44. PubMed ID: 7878476
[No Abstract] [Full Text] [Related]
11. Prognostic value of cyclin D2 mRNA expression in newly diagnosed multiple myeloma treated with high-dose chemotherapy and tandem autologous stem cell transplantations.
Hanamura I; Huang Y; Zhan F; Barlogie B; Shaughnessy J
Leukemia; 2006 Jul; 20(7):1288-90. PubMed ID: 16688228
[No Abstract] [Full Text] [Related]
12. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
Iversen PO; Wisløff F; Gulbrandsen N
Clin Nutr; 2010 Aug; 29(4):488-91. PubMed ID: 20044183
[TBL] [Abstract][Full Text] [Related]
13. New drugs in multiple myeloma and the significance of autologous stem cell transplants.
Jagannath S
Clin Adv Hematol Oncol; 2009 Mar; 7(3):178-9. PubMed ID: 19398940
[No Abstract] [Full Text] [Related]
14. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
[TBL] [Abstract][Full Text] [Related]
15. Transplantation for amyloidosis.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
[TBL] [Abstract][Full Text] [Related]
16. [Role of interferon in the treatment of multiple myeloma].
Shimazaki C
Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
[TBL] [Abstract][Full Text] [Related]
17. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
Hayashi T; Yasui H; Kawakami K; Ikeda H; Takahashi F; Kobayashi T; Nishimura S; Ishida T; Imai K; Shinomura Y
Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701
[TBL] [Abstract][Full Text] [Related]
18. [Multiple myeloma].
Handa H
Rinsho Ketsueki; 2014 Feb; 55(2):201-12. PubMed ID: 24598188
[No Abstract] [Full Text] [Related]
19. Plasma cell disorders: an historical perspective.
Munshi NC
Hematology Am Soc Hematol Educ Program; 2008; ():297. PubMed ID: 19074099
[No Abstract] [Full Text] [Related]
20. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
